Tiedemann Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$313K Hold
380
0.01% 213
2023
Q2
$273K Sell
380
-4
-1% -$3.08K 0.01% 211
2023
Q1
$316K Sell
384
-5
-1% -$3.77K 0.01% 199
2022
Q4
$281K Buy
389
+9
+2% +$6.64K 0.01% 201
2022
Q3
$262K Hold
380
0.02% 192
2022
Q2
$225K Sell
380
-8
-2% -$5.2K 0.02% 204
2022
Q1
$271K Buy
388
+8
+2% +$5.06K 0.01% 239
2021
Q4
$240K Hold
380
0.01% 255
2021
Q3
$230K Sell
380
-20
-5% -$12.4K 0.01% 270
2021
Q2
$224K Sell
400
-27
-6% -$13.7K 0.01% 334
2021
Q1
$201K Buy
427
+13
+3% +$6.33K 0.01% 318
2020
Q4
$200K Sell
414
-394
-49% -$213K 0.01% 306
2020
Q3
$453K Sell
808
-34
-4% -$20.6K 0.02% 231
2020
Q2
$524K Sell
842
-56
-6% -$31.8K 0.03% 210
2020
Q1
$438K Buy
898
+103
+13% +$42.5K 0.03% 212
2019
Q4
$299K Sell
795
-22
-3% -$7.4K 0.01% 245
2019
Q3
$226K Buy
817
+122
+18% +$36.1K 0.01% 283
2019
Q2
$218K Sell
695
-476
-41% -$158K 0.01% 274
2019
Q1
$480K Buy
1,171
+135
+13% +$55.6K 0.02% 305
2018
Q4
$387K Buy
1,036
+323
+45% +$118K 0.02% 323
2018
Q3
$288K Buy
713
+18
+3% +$6.85K 0.02% 262
2018
Q2
$240K Buy
+695
New +$217K 0.02% 268

Other funds holding REGN